Loflatil (loperamide, simethicone) coated tablets №100

Description

Loflatil composition
active substances: loperamide hydrochloride, simethicone;
1 tablet contains loperamide hydrochloride 2 mg, simethicone 125 mg;
Excipients: microcrystalline cellulose, aluminum-magnesium silicate, lactose monohydrate, calcium hydrogen phosphate, colloidal anhydrous silica, povidone K-30, stearic acid, croscarmellose sodium, coating Opadry II 85G52482 yellow: alcohol 17 and polyvinyl alcohol , polyethylene glycols, lecithin, iron oxide yellow (E 172).

Dosage form
Coated tablets.

Pharmacological properties
Loflatil belongs to the group of combined antidiarrheal drugs that inhibit intestinal peristalsis.
The active components of this drug – loperamide hydrochloride and simethicone – in the complex have an enhanced effect.
Loperamide hydrochloride is able to bind to the receptors of the intestinal walls, as a result of which its peristalsis is inhibited.
The action of the drug entails an increase in the transit time of the intestine, due to which the resorption of water and ionic solutions, responsible for the transmission of impulses – electrolytes, is enhanced.
Loperamide does not have a central effect on the body. Does not lead to changes in the physiological microflora in the intestine or an increase in the tone of the anus sphincter.
Simethicone, in turn, is an inert surfactant with defoaming properties. As a result, its intake suppresses the symptoms of diarrhea, flatulence, bloating and cramps.

Indications
Loflatil is used to treat diarrhea, regardless of its cause, that is, any etiology.
Effective for diarrhea, accompanied by the absence of gas discharge from the intestines, and, as a result, abdominal discomfort, spastic pain and flatulence.

Contraindications
Do not apply if the patient has hypersensitivity (allergy).
The drug should be administered with caution to patients with severely impaired liver function, since their first pass metabolism is slowed down.
This drug should not be used as monotherapy for acute dysentery, which is characterized by bloody stools and high fever.
The use of this drug is contraindicated in patients with acute ulcerative colitis or pseudomembranous colitis if they are caused by treatment with broad-spectrum antibiotics.

Children
It is not used in pediatrics until the age of 12.

Application during pregnancy and lactation
For the treatment of pregnant women, it can be used with great caution, in urgent need.
If there is a need to take this drug, then during treatment, lactation (breastfeeding) should be suspended.

Method of administration and dosage
Adults and children over 12 years old take an initial dosage of 2 tablets. Then, after each bowel movement, with liquid contents, another 1 tablet is taken.
The maximum number of tablets you can take per day is 4 tablets.
The duration of such treatment cannot exceed 2 days.
When treating patients with impaired renal function, it is not necessary to reduce the dose of the drug.

Overdose
In case of an overdose, theoretically side effects can be observed in the form of depression of the central nervous system in the form of stupor, impaired coordination, drowsiness, miosis, muscle hypertonia, paralytic intestinal obstruction.
Naloxone is taken as an antidote. It is necessary to monitor the patient’s condition within 48 hours.

Side effects
Therapy with this drug rarely causes adverse reactions, even with prolonged use. In rare cases, the following were observed:

• rash, bullous rash, allergic urticaria, anaphylactic shock;
• toxic epidermal necrolysis;
• constipation, bloating.

If constipation occurs, the drug should be stopped immediately.

Storage conditions and periods
Shelf life of Loflatil is no more than 3 years from the date of manufacture indicated on the package.
Store in a dry place out of the reach of children, at a temperature not exceeding 25 ° C.